Camelot Portfolios’s Celgene Corp CELG Stock Holding History

Camelot Portfolios’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,700	Closed	-$323K	–	176
2015 Q4	$323K	Buy	+2,700	New	+$312K	0.21%	108

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Camelot Portfolios's CELG Position: Q1 2016 in Review

Camelot Portfolios sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 2,700 shares — an estimated $323K sold.

Camelot Portfolios first reported a position in CELG in Q4 2015 and held it in 1 quarter. The position peaked at $323K in Q4 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Camelot Portfolios reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
Camelot Portfolios sold 2,700 Celgene Corp shares in Q1 2016, an estimated $323K.
Camelot Portfolios first reported a position in Celgene Corp in Q4 2015 and held it in 1 quarter.
Camelot Portfolios's Celgene Corp position peaked at $323K in Q4 2015.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Camelot Portfolios's 13F filing for Q1 2016, filed 9 May 2016.